Cardio Diagnostics Inc. is a biotechnology company which makes cardiovascular disease prevention and early detection more accessible, personalized and precise. Cardio Diagnostics Inc., formerly known as Mana Capital Acquisition Corp., is based in DOVER, Del.
| Revenue (Most Recent Fiscal Year) | $0.01M |
| Net Income (Most Recent Fiscal Year) | $-6.50M |
| PE Ratio (Current Year Earnings Estimate) | -- |
| PE Ratio (Trailing 12 Months) | -- |
| PEG Ratio (Long Term Growth Estimate) | -- |
| Price to Sales Ratio (Trailing 12 Months) | 386.38 |
| Price to Book Ratio (Most Recent Quarterly Book Value per Share) | 0.78 |
| Price to Cash Ratio (Most Recent Annual Cash Flow per Share) | -- |
| Pre-Tax Margin (Trailing 12 Months) | -36950.00% |
| Net Margin (Trailing 12 Months) | -36950.00% |
| Return on Equity (Trailing 12 Months) | -78.82% |
| Return on Assets (Trailing 12 Months) | -72.87% |
| Current Ratio (Most Recent Fiscal Quarter) | 15.77 |
| Quick Ratio (Most Recent Fiscal Quarter) | 15.77 |
| Debt to Common Equity (Most Recent Fiscal Quarter) | 0.00 |
| Inventory Turnover (Trailing 12 Months) | -- |
| Book Value per Share (Most Recent Fiscal Quarter) | $3.82 |
| Earnings per Share (Most Recent Fiscal Quarter) | -- |
| Earnings per Share (Most Recent Fiscal Year) | -- |
| Diluted Earnings per Share (Trailing 12 Months) | $-3.38 |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Common Shares Outstanding | 2.96M |
| Free Float | 2.57M |
| Market Capitalization | $6.95M |
| Average Volume (Last 20 Days) | 0.07M |
| Beta (Past 60 Months) | 2.24 |
| Percentage Held By Insiders (Latest Annual Proxy Report) | 13.30% |
| Percentage Held By Institutions (Latest 13F Reports) | 8.06% |
| Annual Dividend (Based on Last Quarter) | $0.00 |
| Dividend Yield (Based on Last Quarter) | 0.00% |